[Federal Register Volume 89, Number 83 (Monday, April 29, 2024)]
[Notices]
[Pages 33352-33353]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-09145]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[30Day-24-1074]


Agency Forms Undergoing Paperwork Reduction Act Review

    In accordance with the Paperwork Reduction Act of 1995, the Centers 
for Disease Control and Prevention (CDC) has submitted the information 
collection request titled ``Colorectal Cancer Control Program (CRCCP) 
Monitoring Activities'' to the Office of Management and Budget (OMB) 
for review and approval. CDC previously published a ``Proposed Data 
Collection Submitted for Public Comment and Recommendations'' notice on 
December 22, 2023 to obtain comments from the public and affected 
agencies. CDC received one comment related to the previous notice. This 
notice serves to allow an additional 30 days for public and affected 
agency comments.
    CDC will accept all comments for this proposed information 
collection project. The Office of Management and Budget is particularly 
interested in comments that:
    (a) Evaluate whether the proposed collection of information is 
necessary for the proper performance of the functions of the agency, 
including whether the information will have practical utility;
    (b) Evaluate the accuracy of the agencies estimate of the burden of 
the proposed collection of information, including the validity of the 
methodology and assumptions used;
    (c) Enhance the quality, utility, and clarity of the information to 
be collected;
    (d) Minimize the burden of the collection of information on those 
who are to respond, including, through the use of appropriate 
automated, electronic, mechanical, or other technological collection 
techniques or other forms of information technology, e.g., permitting 
electronic submission of responses; and
    (e) Assess information collection costs.
    To request additional information on the proposed project or to 
obtain a copy of the information collection plan and instruments, call 
(404) 639-7570. Comments and recommendations for the proposed 
information collection should be sent within 30 days of publication of 
this notice to www.reginfo.gov/public/do/PRAMain. Find this particular 
information collection by selecting ``Currently under 30-day Review--
Open for Public Comments'' or by using the search function. Direct 
written comments and/or suggestions regarding the items contained in 
this notice to the Attention: CDC Desk Officer, Office of Management 
and Budget, 725 17th Street NW, Washington, DC 20503 or by fax to (202) 
395-5806. Provide written comments within 30 days of notice 
publication.

Proposed Project

    Colorectal Cancer Control Program (CRCCP) Monitoring Activities 
(OMB Control No. 0920-1074)--Reinstatement--National Center for Chronic 
Disease Prevention and Health Promotion (NCCDPHP), Centers for Disease 
Control and Prevention (CDC).

Background and Brief Description

    CDC is requesting a Reinstatement of OMB No. 0920-1074. Colorectal 
cancer (CRC) is the second leading cause of death from cancer in the 
United States among cancers that affect both men and women. There is 
substantial evidence that CRC screening reduces the incidence of and 
death from the disease. Screening for CRC can detect disease early when 
treatment is more effective, and prevent cancer by finding and removing 
precancerous polyps. Of individuals diagnosed with early stage CRC, 
more than 90% live five or more years. To reduce CRC morbidity, 
mortality, and associated costs, use of CRC screening tests must be 
increased among age-eligible adults with the lowest CRC screening 
rates.
    The purpose of the Colorectal Cancer Control Program (CRCCP) is to 
partner with health systems and their individual primary care clinics 
to implement evidence-based interventions (EBIs) to increase CRC 
screening among defined populations of adults ages 50-75 that have CRC 
screening rates lower than the national, regional, or local rate. In 
2020, CDC issued the funding opportunity, Public Health and Health 
System Partnerships to Increase Colorectal Cancer Screening in Clinical 
Settings (DP20-2002), a five-year cooperative agreement to increase CRC 
screening among defined populations of adults ages 50-75 that have CRC 
screening rates lower than the national, regional, or local rate. DP20-
2002 funds recipients to partner with health systems and their primary 
care clinics to implement multiple EBIs, partner with organizations to 
support implementation of EBIs in those clinics, and collect high-
quality clinic-level data to monitor EBI implementation and assess 
screening rate changes.
    CDC proposes information collection using three data collection 
tools: the Annual Awardee Survey, Clinic-Level Data Collection 
Instrument, and Quarterly Program Update.
    The Annual Awardee Survey is administered once per year and 
assesses: program management, clinic readiness assessment activities, 
data management, technical assistance (TA) needs, partnerships, and the 
effect of COVID-19 on CRC implementation. The Clinic-Level Information 
Collection Instrument is administered three months following each 
program year end and assesses: health system and

[[Page 33353]]

clinic characteristics; program reach; CRC screening practices and 
outcomes; clinics' quality improvement and monitoring activities; EBI 
implementation, and additional factors that affect EBI implementation 
over time. The Quarterly Program Update is administered in the month 
following each program quarter (i.e., October, January, April, July) 
and collects standardized recipient-level information on aspects of 
program management, including: quarterly program expenditures, current 
staff vacancies, program successes and challenges, current TA needs, 
and the effect of COVID-19 on CRCCP implementation at the recipient 
level. These data are collected quarterly to facilitate rapid reporting 
of programmatic information to support CDC program consultants in 
providing tailored and meaningful TA.
    This information collection enables CDC to gauge progress in 
meeting CRCCP program goals and monitor implementation activities, 
evaluate outcomes, and identify recipients' TA needs. In addition, data 
collected will inform program improvement and help identify successful 
activities that need to be maintained, replicated, or expanded. OMB 
approval is requested for three years. The total estimated annualized 
burden is 760 hours. There is no cost to respondents other than their 
time to participate.

                                        Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
                                                                                     Number of    Average burden
          Type of respondent                    Form name            Number of     responses per   per response
                                                                    respondents     respondent        (in hr)
----------------------------------------------------------------------------------------------------------------
CRCCP Recipients......................  CRCCP Annual Awardee                  35               1           15/60
                                         Survey.
                                        CRCCP Clinic-level                    35              24           50/60
                                         Information Collection
                                         Instrument.
                                        CRCCP Quarterly Program               35               4           22/60
                                         Update.
----------------------------------------------------------------------------------------------------------------


Jeffrey M. Zirger,
Lead, Information Collection Review Office, Office of Public Health 
Ethics and Regulations, Office of Science, Centers for Disease Control 
and Prevention.
[FR Doc. 2024-09145 Filed 4-26-24; 8:45 am]
BILLING CODE 4163-18-P